Zhittya Genesis Medicine Inc.
Dr. Jack Jacobs is president of Zhittya Genesis, a biopharmaceutical company developing a biological drug which triggers angiogenesis and neurogenesis. He leads the company's efforts to obtain FDA approval for its drug to treat Parkinson's Disease, ALS, Alzheimer's, Multiple sclerosis, and enhance stroke recovery.
Angiogenesis in the Brain to Reverse Parkinson's Disease, Alzheimer's Disease and More!
May 13, 2019, 11:45 am - 12:45 pm PDT
New Frontiers in Healthcare: Disease Reversal Through Angiogenesis
May 15, 2019, 11:45 am - 12:30 pm PDT